[Federal Register Volume 87, Number 145 (Friday, July 29, 2022)]
[Notices]
[Pages 45775-45776]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-16335]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Injury 
Prevention and Control (BSC, NCIPC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Board of Scientific Counselors, 
National Center for Injury Prevention and Control (BSC, NCIPC or 
Board). This meeting is partially open to the public. There will be 15 
minutes allotted for public comments at the end of the open session 
from 1:00 p.m. to 1:15 p.m., EDT.

DATES: The meeting will be held on August 23, 2022, from 11:00 a.m. to 
1:15 p.m., EDT (OPEN); and from 1:30 p.m. to 4:30 p.m., EDT (CLOSED).

ADDRESSES: Open Session: Webinar, Atlanta, Georgia. All participants 
must register using the link provided to attend the open meeting: 
https://dceproductions.zoom.us/meeting/register/tZYtd-iurzIvHNDz3Nb2Kl4NqksXHAhcwZnV.
    Closed Session: Teleconference.

FOR FURTHER INFORMATION CONTACT: Arlene Greenspan, DrPH, MPH, PT, 
Associate Director for Science, NCIPC, CDC, 4770 Buford Highway, NE, 
Mailstop S-1069, Atlanta, Georgia 30341; Telephone: (770) 488-1279; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Portions of the meeting referenced above 
will be closed to the public in accordance with provisions set forth in 
Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of 
the Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer,

[[Page 45776]]

CDC, pursuant to Public Law 92-463 (5 U.S.C. app. 2).
    Purpose: The Board will: (1) conduct, encourage, cooperate with, 
and assist other appropriate public health authorities, scientific 
institutions, and scientists in the conduct of research, 
investigations, experiments, demonstrations, and studies relating to 
the causes and strategies related to the prevention of injury and 
violence; (2) assist States and other entities in preventing 
intentional and unintentional injuries and in promoting health and 
well-being; and (3) conduct and assist in research and control 
activities related to injury.
    The BSC, NCIPC makes recommendations regarding policies, 
strategies, objectives, and priorities, and reviews progress toward 
injury and violence prevention. The Board provides advice on the 
appropriate balance of intramural and extramural research, and guidance 
on the needs, structure, progress, and performance of intramural 
programs. The Board also provides guidance on extramural scientific 
program matters, including the: (1) review of extramural research 
concepts for funding opportunity announcements; (2) conduct of 
Secondary Peer Review of extramural research grant applications, 
cooperative agreement applications, and contract applications received 
in response to funding opportunity announcements as they relate to the 
Center's programmatic balance and mission; (3) submission of secondary 
review recommendations to the Center Director of applications to be 
considered for funding support; (4) review of research portfolios; and 
(5) review of program proposals.
    Matters To Be Considered: The open session of the meeting will 
include discussions on an NCIPC update on Motor Vehicle Injury 
Prevention Research Priorities and on an NCIPC presentation on new 
research priorities in Drowning Prevention Research. The closed session 
of the meeting will focus on the Secondary Peer Review of extramural 
research grant applications received in response to four (4) Notices of 
Funding Opportunities (NOFOs): (1) RFA-CE-22-009--``Rigorous Evaluation 
of Community-Level Substance Use and Overdose Prevention Frameworks 
that Incorporate ACE-Related Prevention Strategies''; (2) RFA-CE-22-
010--``Rigorous Evaluation of Strategies to Prevent Overdose through 
Linking People with Illicit Substance Use Disorders to Recovery Support 
Services''; (3) RFA-CE-22-011--``Understanding Polydrug Use Risk and 
Protective Factors, Patterns, and Trajectories to Prevent Drug 
Overdose''; and (4) RFA-CE-22-013--``Rigorous Evaluation of Community-
Centered Approaches for the Prevention of Community Violence.'' Agenda 
items are subject to change as priorities dictate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-16335 Filed 7-28-22; 8:45 am]
BILLING CODE 4163-18-P